| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $226K | +0.0% |
| R&D Expense | $12.8M | +12.4% |
| SG&A Expense | $12.3M | +35.1% |
| Operating Income | -$142.4M | -601.4% |
| Pre-tax Income | -$166.5M | -778.9% |
| Net Income | -$166.5M | -778.8% |
| EPS (Basic) | -$35.21 | -3812.2% |
| EPS (Diluted) | -$35.21 | -3812.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.8M | +9705.6% |
| Current Assets | $25.0M | +10.1% |
| Total Assets | $25.0M | +10.0% |
| Current Liabilities | $11.5M | +25.1% |
| Total Liabilities | $56.6M | +371.2% |
| Stockholders' Equity | -$31.6M | -396.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.8M | -66.1% |
| Capital Expenditures | $14K | +0.0% |
| Investing Cash Flow | -$3.6M | — |
| Financing Cash Flow | $34.0M | — |
| Free Cash Flow | -$29.8M | -66.1% |